Initiating antiretroviral therapy during HIV infection - Confusion and clarity

被引：13

作者：

Pomerantz, RJ

机构：

[1] Thomas Jefferson Univ, Ctr Human Virol, Dorrance H Hamilton Labs, Dept Med,Div Infect Dis, Philadelphia, PA 19107 USA

[2] Thomas Jefferson Univ, Ctr Human Virol, Dorrance H Hamilton Labs, Dept Biochem,Div Infect Dis, Philadelphia, PA 19107 USA

[3] Thomas Jefferson Univ, Ctr Human Virol, Dorrance H Hamilton Labs, Dept Mol Pharmacol,Div Infect Dis, Philadelphia, PA 19107 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2001年 / 286卷 / 20期

关键词：

D O I：

10.1001/jama.286.20.2597

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2597 / 2599

页数：3

共 26 条

[1]

BHIVA Writing Committee, 2000, HIV Med, V1, P76

[2] Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease [J].

Cameron, DW ;

Heath-Chiozzi, M ;

Danner, S ;

Cohen, C ;

Kravcik, S ;

Maurath, C ;

Sun, E ;

Henry, D ;

Rode, R ;

Potthoff, A ;

Leonard, J .

LANCET, 1998, 351 (9102) :543-549

[3] Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].

Carpenter, CCJ ;

Cooper, DA ;

Fischl, MA ;

Gatell, JM ;

Gazzard, BG ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schechter, M ;

Schooley, RT ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390

[4] A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome [J].

Carr, A ;

Miller, J ;

Law, M ;

Cooper, DA .

AIDS, 2000, 14 (03) :F25-F32

[5]

CHEN R, 2001, 8 C RETR OPP INF FEB

[6] Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: A predictor of long-term mortality in HIV infection [J].

Craib, KJP ;

Strathdee, SA ;

Hogg, RS ;

Leung, B ;

Montaner, JSG ;

OShaughnessy, MV ;

Schechter, MT .

JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :798-800

[7] Sex differences in HIV-1 viral load and progression to AIDS [J].

Farzadegan, H ;

Hoover, DR ;

Astemborski, J ;

Lyles, CM ;

Margolick, JB ;

Markham, RB ;

Quinn, TC ;

Vlahov, D .

LANCET, 1998, 352 (9139) :1510-1514

[8] Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage [J].

Giorgi, JV ;

Hultin, LE ;

McKeating, JA ;

Johnson, TD ;

Owens, B ;

Jacobson, LP ;

Shih, R ;

Lewis, J ;

Wiley, DJ ;

Phair, JP ;

Wolinsky, SM ;

Detels, R .

JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :859-870

[9] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].

Hammer, SM ;

Squires, KE ;

Hughes, MD ;

Grimes, JM ;

Demeter, LM ;

Currier, JS ;

Eron, JJ ;

Feinberg, JE ;

Balfour, HH ;

Dayton, LR ;

Chodakewitz, JA ;

Fischl, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733

[10] Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy [J].

Hogg, RS ;

Yip, B ;

Chan, KJ ;

Wood, E ;

Craib, KJP ;

O'Shaughnessy, MV ;

Montaner, JSG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (20) :2568-2577

← 1 2 3 →